The Business of Drugs examines the history of and market for synthetic drugs. It discusses the development of the first psychedelic drugs by Alexander Shulgin. It examines how MDMA was declared illegal despite research suggesting its beneficial medical effects. It also looks at the rise of synthetic analogs and artificial cannabis. It also discusses how psychedelic drugs can be used in PTSD treatment.